MariMed Share Holder Equity 2012-2024 | MRMD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MariMed share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MariMed share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$222.4B
Boston Scientific (BSX)	$154.8B
Stryker (SYK)	$151B
EssilorLuxottica (ESLOY)	$128.8B
Medtronic (MDT)	$116.5B
Lonza Group Ag (LZAGY)	$48.7B
Haleon (HLN)	$43B
Agilent Technologies (A)	$42.1B
GE HealthCare Technologies (GEHC)	$40.5B
ResMed (RMD)	$34.8B
Terumo (TRUMY)	$27.7B
Koninklijke Philips (PHG)	$25.8B
Zimmer Biomet Holdings (ZBH)	$20.4B
Insulet (PODD)	$20.2B
Baxter (BAX)	$15.7B
Smith & Nephew SNATS (SNN)	$11B
Sunny Optical Technology (SNPTF)	$10B
BellRing Brands (BRBR)	$10B
Bio-Rad Laboratories (BIO)	$9.7B
Demant (WILYY)	$7.9B
Lantheus Holdings (LNTH)	$6.3B
Prestige Consumer Healthcare (PBH)	$4.3B
ICU Medical (ICUI)	$3.9B
Envista Holdings (NVST)	$3.7B
Perrigo (PRGO)	$3.4B
Haemonetics (HAE)	$3.2B
GN Store Nord (GNNDY)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.8B
Neogen (NEOG)	$2.3B